A recent study reveals that a single dose of psilocybin can lead to lasting anatomical changes in the brain, potentially enhancing mental health. Conducted with 28 healthy volunteers, the research showed that these changes remained detectable a month after administration.
Key findings:
- A single dose of psilocybin can induce anatomical changes in the brain.
- Changes in brain structure were still apparent one month after taking psilocybin.
- The participants received a 25mg dose, while a placebo group received only 1mg.
- EEG results indicated a surge in brain entropy within an hour of taking psilocybin.
Prof. Robin Carhart-Harris commented on the findings, stating, “It’s remarkable to see potential anatomical brain changes one month after a single dose of any drug.” This study builds on previous research exploring the therapeutic potential of psychedelics for mental health.
Meanwhile, the Functional Mushroom Council has welcomed new members such as Unicorn Bags and Maine Cap N’ Stem, indicating growing interest in functional mushrooms. M2 Ingredients has also launched M2Brew, a functional mushroom ingredient designed for brewed coffee applications.
Separately, Fungi Perfecti introduced multiple product lines including Grateful Dead Gummies and Host Defense Gummies. Monterey Nutra has released ManeFocus, a premium Lion’s Mane extract with high bioavailability.
This wave of innovation reflects the commitment to bridging the gap between people and fungi. By leading with science and collaboration, stakeholders aim to elevate the role of functional mushrooms in food, beverage, and wellness sectors.
